- Home
- ZIM vs VKTX Comparison
ZIM vs VKTX Comparison
Compare ZIM & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ZIM | VKTX |
|---|---|---|
| Founded | 1945 | 2012 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.7B |
| IPO Year | 2020 | 2014 |
Fundamental Metrics
Financial Performance| Metric | ZIM | VKTX |
|---|---|---|
| Price | $26.39 | $35.55 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 6 | 10 |
| Target Price | $18.18 | ★ $88.00 |
| AVG Volume (30 Days) | 1.6M | ★ 2.2M |
| Earning Date | 05-18-2026 | 04-22-2026 |
| Dividend Yield | ★ 7.50% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.49 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.33 | $21.23 |
| 52 Week High | $29.97 | $43.15 |
Technical Indicators
Market Signals| Indicator | ZIM | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 49.39 | 57.77 |
| Support Level | $25.77 | $33.65 |
| Resistance Level | $29.13 | $36.23 |
| Average True Range (ATR) | 0.48 | 1.89 |
| MACD | -0.03 | 0.20 |
| Stochastic Oscillator | 55.41 | 88.73 |
Price Performance
Historical ComparisonAbout ZIM ZIM Integrated Shipping Services Ltd.
ZIM Integrated Shipping Services Ltd is an asset-light container liner shipping company. It offers tailored services, including land transportation and logistical services, specialized shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. Its services include Cargo Services, Digital Services, Schedules, and Shipping Trades and Lines. Geographically, it derives a majority of its revenue from the Pacific trade region.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.